Elanco Animal Health Inc
F:5EA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.112
20.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Net Margin
Elanco Animal Health Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Elanco Animal Health Inc
NYSE:ELAN
|
11.1B USD |
1%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
31%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
500B USD |
27%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
262.5B CHF |
15%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212B GBP |
16%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
211.3B CHF |
26%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
264.8B USD |
30%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
33%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
209B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
142.3B USD |
16%
|
Elanco Animal Health Inc
Glance View
Elanco Animal Health Inc. emerged from the hallowed halls of Eli Lilly and Company, officially standing on its own in 2018, and immediately carving out its identity as a key player in animal health. The company, headquartered in Greenfield, Indiana, prides itself on working at the intersection of science and animal well-being, bringing innovative solutions to the market. Elanco's operations revolve around two primary business segments: Companion Animal and Farm Animal. In the Companion Animal segment, the focus is squarely on developing products that improve the health and extend the lives of pets, from flea and tick treatments to vaccines that safeguard them against disease. This segment taps into the growing humanization of pets, leveraging the emotional bond between owners and animals to drive demand for premium pet healthcare products. On the other hand, Elanco's Farm Animal segment is deeply woven into the fabric of the agricultural ecosystem, serving the needs of livestock operations around the globe. This division offers a suite of products that enhance the health and productivity of cattle, swine, poultry, and aqua species, addressing concerns from disease prevention to growth efficiency. By providing antibiotics, vaccines, and other nutritional health additives, Elanco helps farmers meet the world's growing demand for protein while complying with the ever-stringent regulations on animal product safety and efficacy. The company's diversified portfolio and its global reach allow it to monetize the vast and varied animal health landscape effectively, positioning itself as a stalwart in the sector dedicated not just to animal care but to elevating the industry standards through innovation and responsible growth.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Elanco Animal Health Inc's most recent financial statements, the company has Net Margin of 0.8%.